Sommaire

Numéro précédent | Numéro suivant

• • ·Editorial board

    Page :A3

    

• Coronary Artery Disease

  • ·Relation Between Plaque Progression and Low-Density Lipoprotein Cholesterol During Aging as Assessed With Serial Long-Term (≥12 Months) Follow-Up Intravascular Ultrasound of the Left Main Coronary Artery

    Page :1419-1423

    Marc Hartmann, Clemens von Birgelen, Gary S. Mintz, Gert K. van Houwelingen, Holger Eggebrecht, Dirk Böse, Heinrich Wieneke, Patrick M.J. Verhorst, Raimund Erbel

    Résumé Résumé Plan Plan  
  • ·Long-Term Prognostic Role of Flow-Mediated Dilatation of the Brachial Artery After Acute Coronary Syndromes Without ST Elevation

    Page :1424-1428

    Emmanouil N. Karatzis, Ignatios Ikonomidis, Georgia D. Vamvakou, Theodore G. Papaioannou, Athanassios D. Protogerou, Ioanna Andreadou, Paraskevi T. Voidonikola, Kalliopi N. Karatzi, Christos M. Papamichael, John P. Lekakis

    Résumé Résumé Plan Plan  
  • ·Prevalence of Metabolic Syndrome After Acute Coronary Syndrome and Its Prognostic Significance

    Page :1429-1434

    Carine Boulon, Marianne Lafitte, Vincent Richeboeuf, Bertrand Paviot, Vincent Pradeau, Pierre Coste, Jacques Bonnet, Thierry Couffinhal

    Résumé Résumé Plan Plan  
  • ·Effect of Clopidogrel Plus Aspirin on ST Segments in Patients With ST-Elevation Acute Myocardial Infarction

    Page :1435-1438

    Mohamed Jabaren, Devang Mahesh Desai, Abdulrahman Arabi, Gautam Kareti, Carol Chen-Scarabelli, Howard Seeman Rosman

    Résumé Résumé Plan Plan
  • ·Prognostic Value of Intraventricular Dyssynchrony According to Clinical Stage of Left Ventricular Impairment

    Page :1439-1445

    Malcolm I. Burgess, Ellen Rozis, Thomas H. Marwick

    Résumé Résumé Plan Plan  
  • ·Effect of Gender on Prognosis Following Percutaneous Coronary Intervention for Stable Angina Pectoris and Acute Coronary Syndromes

    Page :1446-1450

    Ruchira Glaser, Faith Selzer, Alice K. Jacobs, Warren K. Laskey, Sheryl F. Kelsey, Elizabeth M. Holper, Howard A. Cohen, J. Dawn Abbott, Robert L. Wilensky

    Résumé Résumé Plan Plan  
  • ·Comparison With Conventional Therapies of Repeated Sirolimus-Eluting Stent Implantation for the Treatment of Drug-Eluting Coronary Stent Restenosis

    Page :1451-1454

    Young-Hak Kim, Bong-Ki Lee, Duk-Woo Park, Kyoung-Ha Park, Bong-Ryong Choi, Cheol Whan Lee, Myeong-Ki Hong, Jae-Joong Kim, Seong-Wook Park, Seung-Jung Park

    Résumé Résumé Plan Plan
  • ·Safety and Efficacy of the 2.25-mm Sirolimus-Eluting Bx Velocity Stent in the Treatment of Patients With De Novo Native Coronary Artery Lesions: the SIRIUS 2.25 Trial

    Page :1455-1460

    Jeffrey W. Moses, Eugenia Nikolsky, Roxana Mehran, Patrick A. Cambier, William B. Bachinsky, Fred Leya, Richard E. Kuntz, Jeffrey J. Popma, Patricia Schleckser, Hong Wang, Sidney A. Cohen, Martin B. Leon, SIRIUS 2.25 Investigators

    Résumé Résumé Plan Plan  
  • ·Safety and Efficacy of Short-Term Celecoxib Before Elective Percutaneous Coronary Intervention for Stable Angina Pectoris

    Page :1461-1463

    Francesco Pelliccia, Vincenzo Pasceri, Antonino Granatelli, Christian Pristipino, Giulio Speciale, Adriana Roncella, Cinzia Cianfrocca, Giuseppe Mercuro, Giuseppe Richichi

    Résumé Résumé Plan Plan
  • ·Comparison of the Efficacy of Direct Coronary Stenting With Sirolimus-Eluting Stents Versus Stenting With Predilation by Intravascular Ultrasound Imaging (from the DIRECT Trial)

    Page :1464-1467

    Atsushi Hirohata, Yoshihiro Morino, Junya Ako, Ryota Sakurai, Maurice Buchbinder, Ronald P. Caputo, Steven P. Karas, Gregory J. Mishkel, Michael R. Mooney, Charles D. O’Shaughnessy, Albert E. Raizner, Robert L. Wilensky, David O. Williams, Shing-Chiu Wong, Paul G. Yock, Yasuhiro Honda, Jeffrey W. Moses, Peter J. Fitzgerald, DIRECT Investigators

    Résumé Résumé Plan Plan  

• Preventive Cardiology

  • ·Competing Impact of Excess Weight Versus Cardiorespiratory Fitness on Cardiovascular Risk

    Page :1468-1471

    Vanessa A. Diaz, Marty S. Player, Arch G. Mainous, Peter J. Carek, Mark E. Geesey

    Résumé Résumé Plan Plan  
  • ·Multifactor Cardiovascular Disease Risk Reduction in Medically Underserved, High-Risk Patients

    Page :1472-1479

    William L. Haskell, Kathleen Berra, Elizabeth Arias, Dianne Christopherson, Annette Clark, Jan George, Shauna Hyde, Linda Klieman, Jeff Myll

    Résumé Résumé Plan Plan  

• Heart Failure

  • ·Predictors of Clinical Outcomes in Patients Given Carvedilol for Heart Failure

    Page :1480-1484

    Barry Greenberg, Sandra R. Lottes, Jeanenne J. Nelson, Mary Ann Lukas, Michael B. Fowler, Barry M. Massie, William T. Abraham, Edward M. Gilbert, Joseph A. Franciosa, COHERE Participant Physicians

    Résumé Résumé Plan Plan  
  • ·Comparison of 60-Day Mortality in Hospitalized Heart Failure Patients With Versus Without Hypothermia

    Page :1485-1488

    Saeed Payvar, Cesare Orlandi, Wendy Gattis Stough, Uri Elkayam, John Ouyang, S. Ward Casscells, Mihai Gheorghiade, Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Congestive Heart Failure (ACTIV in CHF) Investigators †

    Résumé Résumé Plan Plan  
  • ·Effects of Levosimendan on Right Ventricular Function in Patients With Advanced Heart Failure

    Page :1489-1492

    John T. Parissis, Ioannis Paraskevaidis, Vasiliki Bistola, Dimitrios Farmakis, Fotios Panou, Kallirrhoe Kourea, Maria Nikolaou, Gerasimos Filippatos, Dimitrios Kremastinos

    Résumé Résumé Plan Plan  

• Valvular Heart Disease

  • ·Relation of Patient Age to Outcome of Percutaneous Mitral Valvuloplasty

    Page :1493-1500

    Angelo Ramondo, Massimo Napodano, Chiara Fraccaro, Renato Razzolini, Giuseppe Tarantini, Sabino Iliceto

    Résumé Résumé Plan Plan  
  • ·Effectiveness of Same Day Percutaneous Coronary Intervention Followed by Minimally Invasive Aortic Valve Replacement for Aortic Stenosis and Moderate Coronary Disease (“Hybrid Approach”)

    Page :1501-1503

    Derek R. Brinster, Margaretta Byrne, Campbell D. Rogers, Donald S. Baim, Daniel I. Simon, Gregory S. Couper, Lawrence H. Cohn

    Résumé Résumé Plan Plan

• Cardiomyopathy

  • ·Usefulness of N-Terminal Pro-B-Type Natriuretic Peptide to Predict Clinical Course in Patients With Hypertrophic Cardiomyopathy

    Page :1504-1506

    Bulent Mutlu, Fatih Bayrak, Gokhan Kahveci, Muzaffer Degertekin, Elif Eroglu, Yelda Basaran

    Résumé Résumé Plan Plan  
  • ·Determinants for Clinical Diagnosis of Hypertrophic Cardiomyopathy

    Page :1507-1511

    A. Selcuk Adabag, Michael A. Kuskowski, Barry J. Maron

    Résumé Résumé Plan Plan  

• Miscellaneous

  • ·Electrocardiographic Findings in 888 Patients ≥90 Years of Age

    Page :1512-1514

    Glenn P. Kelley, Mark A. Stellingworth, Stephanie Broyles, D. Luke Glancy

    Résumé Résumé Plan Plan
  • ·Impact of Glomerular Filtration Rate on Minor Troponin T Elevations for Risk Assessment in Patients Undergoing Operation for Abdominal Aortic Aneurysm or Lower Extremity Arterial Obstruction

    Page :1515-1518

    Harm H.H. Feringa, Jeroen J. Bax, Robert de Jonge, Abdou Elhendy, Ron T. van Domburg, Martin Dunkelgrun, Olaf Schouten, Stefanos E. Karagiannis, Radosav Vidakovic, Don Poldermans

    Résumé Résumé Plan Plan  
  • ·Relation of Weights of Intraaneurysmal Thrombi to Maximal Right-to-Left Diameters of Abdominal Aortic Aneurysms

    Page :1519-1524

    William Clifford Roberts, Jong Mi Ko, Gregory John Pearl

    Résumé Résumé Plan Plan  
  • ·Evidence of Left Ventricular Contractile Asynchrony by Echocardiographic Phase Imaging in Patients With Type 2 Diabetes Mellitus and Without Clinically Evident Heart Disease

    Page :1525-1530

    Grigorios Korosoglou, Per M. Humpert, Eva Halbgewachs, Raffi Bekeredjian, Arthur Filusch, Sebastian J. Buss, Michael Morcos, Angelika Bierhaus, Hugo A. Katus, Peter P. Nawroth, Helmut Kuecherer

    Résumé Résumé Plan Plan  

• Methods

  • ·Usefulness of Automated Quantitation of Regional Left Ventricular Wall Motion by a Novel Method of Two-Dimensional Echocardiographic Tracking

    Page :1531-1537

    Keitaro Ogawa, Takeshi Hozumi, Kenichi Sugioka, Yoshiki Matsumura, Masahide Nishiura, Ryoichi Kanda, Yasuhiko Abe, Yasuhiko Takemoto, Minoru Yoshiyama, Junichi Yoshikawa

    Résumé Résumé Plan Plan  

• Cardiovascular Pharmacology

  • ·Effects of Acute Administration of Caffeine on Vascular Function

    Page :1538-1541

    Takashi Umemura, Keiko Ueda, Kenji Nishioka, Takayuki Hidaka, Hiroaki Takemoto, Shuji Nakamura, Daisuke Jitsuiki, Junko Soga, Chikara Goto, Kazuaki Chayama, Masao Yoshizumi, Yukihito Higashi

    Résumé Résumé Plan Plan  

• Review

  • ·Emerging Strategies for Increasing High-Density Lipoprotein

    Page :1542-1549

    James S. Forrester, Prediman K. Shah

    Résumé Résumé Plan Plan  

• From the Editor

  • ·Atherosclerosis: Its Cause and Its Prevention

    Page :1550-1555

    William Clifford Roberts

    Plan Plan  

• Readers' Comments

  • ·Putting Emphasis on the First Part of a Biochemical Cascade

    Page :1556

    Robert Lee Bloomfield, Steve Brian Knisely, Carolyn Frances Pedley, Paula Shropshire Stuart

    
  • ·Prognostic Role of Body Mass Index After Acute Myocardial Infarction

    Page :1556-1557

    Mitja Lainscak, Linn M.A. Kennedy, Ronnie Willenheimer, Stefan D. Anker

    
  • ·Prediction of Outcome in Patients Undergoing Surgery for Tricuspid Regurgitation

    Page :1557

    Itzhak Shapira

    
  • ·Impact of Enzyme Replacement Therapy on Cardiac Morphology and Function and Late Enhancement in Fabry’s Cardiomyopathy

    Page :1557-1558

    Charles Y. Lui, Hyunsu Ju

    
  • ·Cardiomyopathy and Myopathy in Left Ventricular Noncompaction

    Page :1558

    Claudia Stöllberger, Josef Finsterer